|
|
 |
|
Viewing report
|
|
|
|
OTC Pharmaceuticals in Austria - Industry and Country Analysis
MarketLine, Aug 2011, Pages: 64
Project Synopsis:
OTC Pharmaceuticals in Austria – Industry and Country Analysis provides five forces Industry analysis, along with PESTLE country analysis of Austria. This report concludes with profiles of the leading companies in the Austrian OTC pharmaceuticals market.
Project Description:
Includes market value/volume, geographical segmentation, and five forces (buyer power, supplier power, new entrants, substitutes, and rivalry) analysis of the OTC Pharmaceuticals Industry in Austria The PESTLE analysis section analyzes the current challenges, future prospects and risks across political, economic, social, technological, legal and environmental areas of the country.
Scope:
- Contains data on market value, volume and/or segmentation for OTC Pharmaceuticals in Austria.
- Incorporates in-depth five forces competitive environment analysis.
- analyzes the political, economic, social, technological, legal and environmental (PESTLE) structure of Austria.
- The leading companies are identified with supporting key financial metrics (where available)
Market Definition:
The OTC pharmaceuticals market values consists of the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).
Highlights:
The Austrian OTC pharmaceuticals market generated total revenues of $825 million in 2009, representing a compound annual growth rate (CAGR) of 2.8% for the period spanning 2005-2009.
Cough and cold preparations sales proved the most lucrative for the Austrian OTC pharmaceuticals market in 2009, generating total revenues of $204.5 million, equivalent to 24.8% of the market's overall value.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.8% for the five-year period 2009-2014, which is expected to drive the market to a value of $947.8 million by the end of 2014.
Reasons to purchase:
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
|
|
|
|
